JP2010535218A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535218A5
JP2010535218A5 JP2010519949A JP2010519949A JP2010535218A5 JP 2010535218 A5 JP2010535218 A5 JP 2010535218A5 JP 2010519949 A JP2010519949 A JP 2010519949A JP 2010519949 A JP2010519949 A JP 2010519949A JP 2010535218 A5 JP2010535218 A5 JP 2010535218A5
Authority
JP
Japan
Prior art keywords
optionally substituted
compound according
compound
halo
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010519949A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535218A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/009346 external-priority patent/WO2009017831A1/en
Publication of JP2010535218A publication Critical patent/JP2010535218A/ja
Publication of JP2010535218A5 publication Critical patent/JP2010535218A5/ja
Pending legal-status Critical Current

Links

JP2010519949A 2007-08-01 2008-07-31 炎症および免疫関連用途のためのビニル−アリール誘導体 Pending JP2010535218A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96282307P 2007-08-01 2007-08-01
PCT/US2008/009346 WO2009017831A1 (en) 2007-08-01 2008-07-31 Vinyl-aryl derivatives for inflammation and immune-related uses

Publications (2)

Publication Number Publication Date
JP2010535218A JP2010535218A (ja) 2010-11-18
JP2010535218A5 true JP2010535218A5 (enExample) 2012-11-08

Family

ID=40304694

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010519949A Pending JP2010535218A (ja) 2007-08-01 2008-07-31 炎症および免疫関連用途のためのビニル−アリール誘導体

Country Status (7)

Country Link
US (2) US8349841B2 (enExample)
EP (1) EP2185514A4 (enExample)
JP (1) JP2010535218A (enExample)
AU (1) AU2008282737A1 (enExample)
CA (1) CA2695156A1 (enExample)
TW (1) TW200914440A (enExample)
WO (1) WO2009017831A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1846388A4 (en) 2005-01-25 2011-12-07 Synta Pharmaceuticals Corp THIOPHEN COMPOUNDS FOR IGNITIONS AND THE IMMUNE SYSTEM APPLICATIONS
TW200806641A (en) 2006-01-25 2008-02-01 Synta Pharmaceuticals Corp Substituted aromatic compounds for inflammation and immune-related uses
US7816535B2 (en) 2006-01-25 2010-10-19 Synta Pharmaceuticals Corp. Vinyl-phenyl derivatives for inflammation and immune-related uses
TW200806290A (en) 2006-01-25 2008-02-01 Synta Pharmaceuticals Corp Substituted biaryl compounds for inflammation and immune-related uses
AU2007227210A1 (en) 2006-03-20 2007-09-27 Synta Pharmaceuticals Corp. Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
US8779154B2 (en) 2006-09-26 2014-07-15 Qinglin Che Fused ring compounds for inflammation and immune-related uses
WO2009017831A1 (en) * 2007-08-01 2009-02-05 Synta Pharmaceuticals Corp. Vinyl-aryl derivatives for inflammation and immune-related uses
AU2009300316A1 (en) * 2008-10-01 2010-04-08 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses
US8377970B2 (en) 2009-10-08 2013-02-19 Rhizen Pharmaceuticals Sa Modulators of calcium release-activated calcium channel
US8993612B2 (en) 2009-10-08 2015-03-31 Rhizen Pharmaceuticals Sa Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
KR20120130104A (ko) * 2010-02-01 2012-11-28 닛뽕 케미파 가부시키가이샤 Gpr119 작동약
US10703722B2 (en) 2010-04-27 2020-07-07 Calcimedica, Inc. Compounds that modulate intracellular calcium
JP6112486B2 (ja) 2010-04-27 2017-04-12 カルシメディカ,インク. 細胞内カルシウムを調節する化合物
EP2563759B1 (en) 2010-04-27 2022-04-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
EP2609095A4 (en) 2010-08-27 2014-06-18 Calcimedica Inc COMPOUNDS MODULATING INTRACELLULAR CALCIUM
EP2638032A1 (en) * 2010-11-09 2013-09-18 Synta Pharmaceuticals Corp. Tetrazolyl - tetrahydropyridine compounds for inflammation and immune - related uses
US20120316182A1 (en) 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
US9512116B2 (en) 2012-10-12 2016-12-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
EP3778595B1 (en) 2015-02-27 2021-08-25 Calcimedica, Inc. Pancreatitis treatment
CA2995094A1 (en) 2015-08-07 2017-02-16 Calcimedica, Inc. Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
WO2020053834A1 (en) 2018-09-14 2020-03-19 Rhizen Pharmaceuticals Sa Compositions comprising a crac inhibitor and a corticosteroid and methods of use thereof
TWI885039B (zh) 2020-01-13 2025-06-01 美商邊際分析公司 經取代吡唑并嘧啶及其用途
JP2023528537A (ja) 2020-03-20 2023-07-04 カルシメディカ,インク. 急性肺傷害及び急性呼吸窮迫症候群を処置するための方法及び組成物
CA3198798A1 (en) 2020-11-13 2022-05-19 Kenneth Stauderman Improved synthesis of crac channel inhibitors

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017A (en) * 1849-01-09 Die for bending ttjbe-skelps
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
TWI376370B (en) * 2003-07-23 2012-11-11 Synta Pharmaceuticals Corp Compounds for inflammation and immune-related uses
WO2006004200A1 (ja) * 2004-07-02 2006-01-12 Sankyo Company, Limited ウレア誘導体
KR20140018997A (ko) 2005-01-07 2014-02-13 신타 파마슈티칼스 코프. 염증 및 면역 관련 용도를 위한 화합물
PL1848435T3 (pl) 2005-01-25 2016-08-31 Synta Pharmaceuticals Corp Związki przeciwko zapaleniom i zastosowania związane z odpornością
US7816535B2 (en) * 2006-01-25 2010-10-19 Synta Pharmaceuticals Corp. Vinyl-phenyl derivatives for inflammation and immune-related uses
US20080207641A1 (en) * 2006-11-13 2008-08-28 Synta Pharmaceuticals Corp. Cyclohexenyl-aryl compounds for inflammation and immune-related uses
JO2972B1 (en) * 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
WO2009017831A1 (en) * 2007-08-01 2009-02-05 Synta Pharmaceuticals Corp. Vinyl-aryl derivatives for inflammation and immune-related uses

Similar Documents

Publication Publication Date Title
JP2010535218A5 (enExample)
JP2010509342A5 (enExample)
JP2010535215A5 (enExample)
JP2010535214A5 (enExample)
CA2669695A1 (en) Tetrahydropyridinyl compounds for inflammation and immune-related uses
JP2012504605A5 (enExample)
CN111315737B (zh) 经砜吡啶烷基酰胺取代的杂芳基化合物
ES2303565T3 (es) Derivados de aminobenzamida como inhibidores de la glucogeno sintasa cinasa 3beta.
JP2020537657A5 (enExample)
JP2021518389A (ja) IL−12、IL−23および/またはIFNα応答のモジュレーターとして有用なピリジン含有ヘテロ環式化合物
CN115667239A (zh) 取代吡嗪类化合物,包含其的药物组合物及其用途
JP2008513508A5 (enExample)
JP2009531292A5 (enExample)
JP2012504604A5 (enExample)
JP2008526866A (ja) 炎症及び免疫に関連する用途に用いる化合物
JP2010535218A (ja) 炎症および免疫関連用途のためのビニル−アリール誘導体
JP2006525359A5 (enExample)
JP2012524107A5 (enExample)
JP2012504603A (ja) 炎症および免疫関連の使用のための化合物
JP2013522316A5 (enExample)
JP2022518359A (ja) テトラゾロン置換ステロイド及びその使用
CN114364665B (zh) 调节白介素的前药
JP2004524359A (ja) ケモカインレセプターのモジュレーターとしての新規ピペリジン誘導体
JP2017514865A5 (enExample)
WO2025008732A1 (en) Novel compounds as modulators of il17